Multiparametric PET Suite AI
In PET/CT, standard uptake values (SUVs) alone may not be ideal for determining disease status, as patient diet and weight fluctuations result in variable SUV values. Multiparametric PET provides those coveted absolute numbers, but the exam can be cumbersome, and the requirement of arterial blood sampling can cause pain and put patients at risk. Multiparametric PET Suite AI offers a fully automated workflow that extracts the arterial input function automatically from acquired PET/CT images, eliminating the unnecessary pain and risk associated with arterial lines and sampling. In addition to the standard SUV image, Multiparametric PET Suite AI provides clinical information for the patient report in the form of metabolic rate and distribution volume, further expanding precision medicine.
Ad Statistics
Times Displayed: 49670
Times Visited: 1409 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
"The addition of AIDAN to the Siemens Healthineers Biograph PET/CT portfolio represents a significant advancement in AI application at the scanner level," said John Khoury, Vice President of the Molecular Imaging business at Siemens Healthineers North America. "With AIDAN, we use robust learning technology to accelerate and improve the planning, acquisition, and interpretation of PET/CT."
About Siemens Healthineers
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers' worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance the healthcare provider's ability to provide high-quality, efficient care to patients. In fiscal 2019, which ended on September 30, 2019, Siemens Healthineers, which has approximately 52,000 employees worldwide, generated revenue of €14.5 billion and adjusted profit of €2.5 billion.
Back to HCB News
